Sort   by:  
 Page size 
UnknownTanezumab for the treatment of pain from osteoarthritis of the knee.
Not available
S-EPMC6896791 | biostudies-literature
UnknownProtein and calorie intakes in adult and pediatric subjects with urea cycle disorders participating in clinical trials of glycerol phenylbutyrate.
Not available
S-EPMC4789342 | biostudies-literature
UnknownPharmacology and safety of glycerol phenylbutyrate in healthy adults and adults with cirrhosis.
Not available
S-EPMC3733097 | biostudies-literature
UnknownAmmonia control in children with urea cycle disorders (UCDs); phase 2 comparison of sodium phenylbutyrate and glycerol phenylbutyrate.
Not available
S-EPMC4880058 | biostudies-literature
UnknownPhase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: safety, pharmacokinetics and ammonia control.
Not available
S-EPMC2905228 | biostudies-literature
UnknownGlycerol phenylbutyrate treatment in children with urea cycle disorders: pooled analysis of short and long-term ammonia control and outcomes.
Not available
S-EPMC4382922 | biostudies-literature
UnknownUrinary phenylacetylglutamine (U-PAGN) concentration as biomarker for adherence in patients with urea cycle disorders (UCD) treated with glycerol phenylbutyrate.
Not available
S-EPMC5471406 | biostudies-literature
UnknownAmmonia control in children ages 2 months through 5 years with urea cycle disorders: comparison of sodium phenylbutyrate and glycerol phenylbutyrate.
Not available
S-EPMC4017326 | biostudies-literature
UnknownUrinary phenylacetylglutamine as dosing biomarker for patients with urea cycle disorders.
Not available
S-EPMC3608516 | biostudies-literature
UnknownSelf-reported treatment-associated symptoms among patients with urea cycle disorders participating in glycerol phenylbutyrate clinical trials.
Not available
S-EPMC4804346 | biostudies-literature
Sort   by:  
 Page size